Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-09-29 Purchase | 2026-10-01 8:13 pm | Helus Pharma Inc. | HELP | Cavers Greg Chief Financial Officer | 3,000 | $12.91 | $38,730 | 128,937 (Indirect Direct) | View |
| 2026-09-21 Purchase | 2026-09-21 5:07 pm | CYBIN INC. | CYBN | Halstead Michael Chief Executive Officer | 100,000 | $13.47 | $1,347,050 | 168,568 (Direct) | View |
| 2026-09-08 Purchase | 2026-09-11 09:04 am | CYBIN INC. | CYBN | Glavine Paul Chief Growth Officer | 100,000 | $12.47 | $1,247,190 | 4,502,193 (Indirect Direct) | View |
| 2026-09-08 Purchase | 2026-09-11 09:03 am | CYBIN INC. | CYBN | Glavine Paul Chief Growth Officer | 100,000 | $12.47 | $1,247,190 | 4,502,193 (Indirect Direct) | View |
| 2026-09-08 Purchase | 2026-09-11 09:01 am | CYBIN INC. | CYBN | So Eric H. L. Executive Chair | 100,000 | $12.39 | $1,238,670 | 4,518,630 (Indirect Direct) | View |
| 2026-09-04 Purchase | 2026-09-10 06:21 am | CYBIN INC. | CYBN | So Eric H. L. Executive Chair | 100,000 | $12.09 | $1,208,900 | 4,418,630 (Indirect Direct) | View |
| 2026-09-03 Purchase | 2026-09-10 06:19 am | CYBIN INC. | CYBN | Glavine Paul Chief Growth Officer | 100,000 | $11.78 | $1,178,280 | 4,402,193 (Indirect Direct) | View |
| 2026-09-01 Purchase | 2026-09-09 5:47 pm | CYBIN INC. | CYBN | So Eric H. L. Executive Chair | 95,000 | $11.8 | $1,121,475 | 4,318,630 (Indirect Direct) | View |
| 2026-08-31 Purchase | 2026-09-09 11:03 am | CYBIN INC. | CYBN | Glavine Paul Chief Growth Officer | 90,000 | $11.59 | $1,042,677 | 4,302,193 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
Ownership | 2026-10-26 1:49 pm | N/A N/A | Helus Pharma Inc. | HELP | Lewis-Hall Freda C Director | 0 | $0 | 150,000 (Direct) | View |
Ownership | 2026-10-26 11:17 am | N/A N/A | Helus Pharma Inc. | HELP | Inamdar Amir Director | 0 | $0 | 294,490 (Indirect) | View |
Ownership | 2026-10-23 7:19 pm | N/A N/A | Helus Pharma Inc. | HELP | Froese Grant Director | 0 | $0 | 181,000 (Indirect) | View |
Ownership | 2026-10-23 7:16 pm | N/A N/A | Helus Pharma Inc. | HELP | Hoskins Eric Director | 0 | $0 | 188,895 (Indirect) | View |
Ownership | 2026-10-23 7:13 pm | N/A N/A | Helus Pharma Inc. | HELP | Lawson Mark Director | 0 | $0 | 160,026 (Direct) | View |
Ownership | 2026-10-23 7:11 pm | N/A N/A | Helus Pharma Inc. | HELP | Firestone Theresa Director | 0 | $0 | 76,879 (Direct) | View |
| 2026-09-30 Option Award | 2026-10-01 9:16 pm | N/A N/A | Helus Pharma Inc. | HELP | So Eric H. L. Director | 248,000 | $0 | 4,766,630 (Direct) | View |
Ownership | 2026-10-01 8:13 pm | N/A N/A | Helus Pharma Inc. | HELP | Cavers Greg Chief Financial Officer | 0 | $0 | 192,605 (Direct) | View |
| 2026-09-30 Option Award | 2026-10-01 8:12 pm | N/A N/A | Helus Pharma Inc. | HELP | Glavine Paul Chief Growth Officer | 248,000 | $0 | 4,750,191 (Direct) | View |
Ownership | 2026-09-17 5:04 pm | N/A N/A | CYBIN INC. | CYBN | Halstead Michael Chief Executive Officer | 0 | $0 | 1,426,902 (Direct) | View |
Ownership | 2026-09-09 5:45 pm | N/A N/A | CYBIN INC. | CYBN | So Eric H. L. Executive Chair | 0 | $0 | 4,328,894 (Direct) | View |
Ownership | 2026-09-09 11:00 am | N/A N/A | CYBIN INC. | CYBN | Glavine Paul Chief Growth Officer | 0 | $0 | 4,317,456 (Direct) | View |